{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T06:22:05Z","timestamp":1775370125445,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1124\/jpet.300.2.478","type":"journal-article","created":{"date-parts":[[2003,7,27]],"date-time":"2003-07-27T00:50:36Z","timestamp":1059267036000},"page":"478-486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Preclinical Pharmacology of Fiduxosin, a Novel \u03b11-Adrenoceptor Antagonist with Uroselective Properties"],"prefix":"10.1016","volume":"300","author":[{"given":"Arthur A.","family":"Hancock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Buckner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Brune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy A.","family":"Esbenshade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynne M.","family":"Ireland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sweta","family":"Katwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Milicic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"James F.","family":"Kerwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.300.2.478_bib1","first-page":"1","article-title":"Introduction: the changing therapy of benign prostatic hyperplasia.","volume":"29","author":"Altwein","year":"1995","journal-title":"Scand J Urol Nephrol"},{"key":"10.1124\/jpet.300.2.478_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.med.48.1.177","article-title":"Management of benign prostatic hyperplasia.","volume":"48","author":"Barry","year":"1997","journal-title":"Annu Rev Med"},{"key":"10.1124\/jpet.300.2.478_bib3","first-page":"A445","article-title":"Alpha-1 adrenoceptor blockade inhibits detrusor instability in rats with bladder outlet obstruction.","volume":"12","author":"Broten","year":"1998","journal-title":"FASEB J"},{"key":"10.1124\/jpet.300.2.478_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ddr.430340304","article-title":"Pharmacological antagonism of \u03b1-adrenergic agonist induced increases in canine intraurethral pressure in vivo.","volume":"34","author":"Brune","year":"1995","journal-title":"Drug Dev Res"},{"key":"10.1124\/jpet.300.2.478_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/jpet.300.2.487","article-title":"Effect of Fiduxosin, an antagonist selective for \u03b11A- and \u03b11D-adrenoceptors on intraurethral and arterial pressure responses in conscious dogs.","volume":"300","author":"Brune","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.2.478_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0031-6997(25)06780-8","article-title":"IV. International Union of Pharmacology nomenclature of adrenoceptors.","volume":"46","author":"Bylund","year":"1994","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.300.2.478_bib7","doi-asserted-by":"crossref","first-page":"11589","DOI":"10.1073\/pnas.94.21.11589","article-title":"Decreased blood pressure response in mice deficient of the \u03b11b-adrenergic receptor.","volume":"94","author":"Cavalli","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.300.2.478_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0014-5793(98)00024-6","article-title":"Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoforms.","volume":"422","author":"Chang","year":"1998","journal-title":"FEBS Lett"},{"issue":"Suppl 2","key":"10.1124\/jpet.300.2.478_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000052284","article-title":"Cardiovascular effects of alpha-blockers used for the treatment of symptomatic BPH: impact on safety and well-being.","volume":"34","author":"de Mey","year":"1998","journal-title":"Eur Urol"},{"issue":"Suppl B","key":"10.1124\/jpet.300.2.478_bib10","first-page":"11","article-title":"Latest results of long-term benefits of tamsulosin on the prostate and bladder.","volume":"36","author":"de Mey","year":"2000","journal-title":"Drugs of Today"},{"key":"10.1124\/jpet.300.2.478_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s002100100413","article-title":"In vitro and in vivo uroselectivity of B8805\u2013033, an antagonist with high affinity at prostatic \u03b11A- vs. \u03b11B- and \u03b11D-adrenoceptors.","volume":"353","author":"Eltze","year":"2001","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/jpet.300.2.478_bib12","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/sj.bjp.0701207","article-title":"Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification.","volume":"121","author":"Ford","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.300.2.478_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0026-895X(25)08700-0","volume":"49","author":"Ford","year":"1996","journal-title":"Mol Pharmacol"},{"issue":"Suppl","key":"10.1124\/jpet.300.2.478_bib14","first-page":"112P","article-title":"Characterisation of \u03b11-adrenoceptors in isolated anococcygeus muscle of rat.","volume":"109","author":"Ford","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.300.2.478_bib15","first-page":"267A","article-title":"Effects of novel alpha-1c adrenergic receptor antagonists on the contraction of human prostate smooth muscle.","volume":"151","author":"Forray","year":"1995","journal-title":"J Urol"},{"key":"10.1124\/jpet.300.2.478_bib16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0022-3565(25)23780-6","article-title":"Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.","volume":"248","author":"Gillis","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl","key":"10.1124\/jpet.300.2.478_bib17","first-page":"228","article-title":"Changes in \u03b11 adrenergic receptor (AR) subtype gene expression during bladder outlet obstruction of rats.","volume":"163","author":"Hampel","year":"2000","journal-title":"J Urol"},{"key":"10.1124\/jpet.300.2.478_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/(SICI)1098-2299(19960901)39:1<54::AID-DDR7>3.0.CO;2-J","article-title":"\u03b11-Adrenoceptor subtypes: a synopsis of their pharmacology and molecular biology.","volume":"39","author":"Hancock","year":"1996","journal-title":"Drug Dev Res"},{"key":"10.1124\/jpet.300.2.478_bib19","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0022-3565(24)37428-2","article-title":"Actions of A-131701, a novel, selective antagonist for \u03b11A- compared to \u03b11B-adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity.","volume":"285","author":"Hancock","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.2.478_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1098-2299(199808)44:4<140::AID-DDR2>3.0.CO;2-R","article-title":"Pharmacological characterization of A-131701, a novel, \u03b11-adrenoceptor antagonist selective for \u03b11A- and \u03b11D- compared to \u03b11B-adrenoceptors.","volume":"44","author":"Hancock","year":"1998","journal-title":"Drug Dev Res"},{"key":"10.1124\/jpet.300.2.478_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0090-4295(94)80009-X","article-title":"Effect of alpha1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.","volume":"44","author":"Kenny","year":"1994","journal-title":"Urology"},{"key":"10.1124\/jpet.300.2.478_bib22","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0022-3565(24)36701-1","article-title":"Pharmacological characterization of the uroselective Alpha-1 antagonist Rec 15\/2739 (SB 216469): role of the Alpha-1L adrenoceptor in tissue selectivity, part I.","volume":"281","author":"Leonardi","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.2.478_bib23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0022-5347(01)62836-2","article-title":"Alpha1-adrenergic receptor subtypes in human detrusor.","volume":"160","author":"Malloy","year":"1998","journal-title":"J Urol"},{"key":"10.1124\/jpet.300.2.478_bib24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0022-3565(24)36764-3","article-title":"Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists.","volume":"282","author":"Martin","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.2.478_bib25","first-page":"25S","article-title":"The majority of prostatic \u03b1-adrenoceptors are of the atypical \u03b11L-receptor subtype.","volume":"159","author":"Mason","year":"1998","journal-title":"J Urol"},{"issue":"Suppl 2","key":"10.1124\/jpet.300.2.478_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1464-410X.2000.00094.x","article-title":"\u03b1-Blockers and lower urinary tract function: more than smooth muscle relaxation?","volume":"86","author":"Michel","year":"2000","journal-title":"BJU Int"},{"key":"10.1124\/jpet.300.2.478_bib27","first-page":"23","article-title":"Functional subclassification of vascular \u03b11-adrenoceptors.","volume":"6","author":"Muramatsu","year":"1995","journal-title":"Pharmacol Commun"},{"key":"10.1124\/jpet.300.2.478_bib28","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1464-410X.1994.tb09186.x","article-title":"Pharmacological characterization of \u03b11-adrenoceptor subtypes in the human prostate: functional and binding studies.","volume":"74","author":"Muramatsu","year":"1994","journal-title":"Br J Urol"},{"key":"10.1124\/jpet.300.2.478_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0090-4295(98)00054-5","article-title":"Overview of \u03b1-blocker therapy for benign prostatic hyperplasia.","volume":"41","author":"Narayan","year":"1998","journal-title":"Urology"},{"key":"10.1124\/jpet.300.2.478_bib30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-5347(17)35544-1","article-title":"Identification, quantification and localization of mRNA for three distinct alpha1 adrenergic receptor subtypes in human prostate.","volume":"150","author":"Price","year":"1993","journal-title":"J Urol"},{"key":"10.1124\/jpet.300.2.478_bib31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0022-3565(24)39060-3","article-title":"An investigation of the uroselective properties of four novel \u03b11a-adrenergic receptor subtype-selective antagonists.","volume":"294","author":"Pulito","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.2.478_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/nau.1930140604","article-title":"Is detrusor instability in elderly males related to the grade of obstruction?","volume":"14","author":"Rosier","year":"1995","journal-title":"Neurourol Urodyn"},{"key":"10.1124\/jpet.300.2.478_bib33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-3565(24)38805-6","article-title":"Pharmacological effect of tamsulosin in relation to dog plasma and tissue concentrations: prostatic and uretheral retention possibly contributes to uroselectivity of tamsulosin.","volume":"296","author":"Sato","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 2","key":"10.1124\/jpet.300.2.478_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1464-410X.2000.00061.x","article-title":"\u03b11-Adrenergic receptors in the lower urinary tract and vascular bed: potential role for the \u03b11d subtype in filling symptoms and effects of ageing on vascular expression.","volume":"85","author":"Schwinn","year":"2000","journal-title":"BJU Int"},{"key":"10.1124\/jpet.300.2.478_bib35","first-page":"265","article-title":"The relationship between histological and clinical response to alpha blockade in men with symptomatic BPH.","volume":"145","author":"Shapiro","year":"1991","journal-title":"J Urol"},{"key":"10.1124\/jpet.300.2.478_bib36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0094-0143(21)00664-9","article-title":"Pathophysiology of clinical benign prostatic hyperplasia.","volume":"22","author":"Shapiro","year":"1995","journal-title":"Urol Clin North Am"},{"key":"10.1124\/jpet.300.2.478_bib37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0169-328X(98)00287-3","article-title":"Alpha1-adrenergic receptors in human spinal cord: specific localized expression of mRNA encoding alpha1-adrenergic receptor subtypes at four distinct levels.","volume":"63","author":"Smith","year":"1999","journal-title":"Mol Brain Res"},{"key":"10.1124\/jpet.300.2.478_bib38","series-title":"Statistical Methods.","author":"Snedecor","year":"1967"},{"key":"10.1124\/jpet.300.2.478_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1254\/jjp.77.61","article-title":"Vascular \u03b11-adrenoceptor subtype selectivity and \u03b11-blocker-induced orthostatic hypotension.","volume":"77","author":"Take","year":"1998","journal-title":"Jpn J Pharmacol"},{"key":"10.1124\/jpet.300.2.478_bib40","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(24)36702-3","article-title":"Pharmacological characterization of the uroselective Alpha-1 antagonist Rec 15\/2739 (SB 216469): role of the Alpha-1L adrenoceptor in tissue selectivity, part II.","volume":"281","author":"Testa","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.2.478_bib41","first-page":"473","article-title":"REC 15\/2739, a new \u03b11-antagonist selective for the lower urinary tract: in vitro studies.","volume":"13","author":"Testa","year":"1994","journal-title":"Neurourol Urodyn"},{"key":"10.1124\/jpet.300.2.478_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-2999(97)89674-4","article-title":"Analysis of alpha1-adrenoceptors in rabbit lower urinary tract and mesenteric artery.","volume":"327","author":"Van der Graaf","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.300.2.478_bib43","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1021\/jm00010a001","article-title":"Discovery of \u03b11a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine.","volume":"38","author":"Wetzel","year":"1995","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.300.2.478_bib44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.bjp.0702541","article-title":"In vitro \u03b11-adrenoceptor pharmacology of Ro-70-0004 and RS-100329, novel \u03b11A-adrenoceptor antagonists.","volume":"127","author":"Williams","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.300.2.478_bib45","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1124\/jpet.300.2.495","article-title":"Modeling of the relationships between pharmacokinetics and blockade of agonist-induced elevation of intraurethral pressure in the conscious dogs treated with \u03b11-adrenoceptor antagonists.","volume":"300","author":"Witte","year":"2002","journal-title":"J Pharmacol Exp Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652435476X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652435476X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.300.2.478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:13:31Z","timestamp":1740006811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652435476X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S002235652435476X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.300.2.478","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical Pharmacology of Fiduxosin, a Novel \u03b11-Adrenoceptor Antagonist with Uroselective Properties","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.300.2.478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}